Largest American Cannabis MSOs: Downward Slope Continues

This article presents the stock performance of each of the 12 largest American cannabis multi-state operators (MSOs) in the munKNEE American Cannabis MSOs Index this week and in the last 6 weeks in descending order, as follows:

  1. TerrAscend (TRSSF): 
  2. Verano (VRNOF): 
    • UP 4.3% this week and
    • UP 10.9% since the end of January (6 weeks)
      • Has a 64% Chance of Financial Distress within 2 years;
    • Average analyst price target is $9.83, a 212.7% increase from the March 10th price of $3.16
      • The highest analyst price target is $16.17, the lowest forecast is $3.31
      • Consensus rating of Strong Hold is based on 3 buy ratings, 1 hold rating and 0 sell ratings of 4 Wall Street analyst offering 12 month price targets for Verano in the last 3 months. Source
    • Read:
  3. Green Thumb (GTBIF): 
    • DOWN 4.1% this week and
    • UP 8.0% since the end of January (6 weeks)
      • Is the only MSO with a  Positive Net Operating Cash Flow
      • Has a 10% Chance of Financial Distress within 2 years;
    • Average analyst price target is $15.29, a 88.8% increase from the March 10th price of $8.10
      • The highest analyst price target is $23.52, the lowest forecast is $10.00
      • Consensus rating of Strong Buy is based on 6 buy ratings, 1 hold ratings and 0 sell ratings of 7 Wall Street analysts offering 12 month price targets for Green Thumb in the last 3 months Source
    • Read:
  4.  Cresco Labs (CRLBF): 
  5. Curaleaf (CURLF): 
    • DOWN 3.9% this week and
    • DOWN 1.6% since the end of January (6 weeks)
      • Has a 39% Chance of Financial Distress within 2 years;
    • Average analyst price target is $7.42, a 100.5% increase from the March 10th price of $3.70
      • The highest analyst price target is $12.00, the lowest forecast is $5.00
      • Consensus rating of Strong Buy is based on 4 buy ratings, 0 hold ratings and 0 sell ratings of 4 Wall Street analysts offering 12 month price targets for Curaleaf in the last 3 months Source
    • Read:
  6. Planet 13 (PLNHF): 
    • No Change this week and
    • DOWN 4.4% since the end of January (6 weeks)
      • Has a 46% Chance of Financial Distress within 2 years;
    • Average analyst price target is $0.95, a 10.5% increase from the March 10th price of $3.85
      • The highest analyst price target is $0.95, the lowest forecast is $0.95
      • Consensus rating of Hold is based on 0 buy ratings, 1 hold rating and 0 sell ratings of 1 Wall Street analyst offering 12 month price targets for Planet 13 in the last 3 months Source
    • Read:
  7. Jushi (JUSHF):
  8. Trulieve (TCNNF): 
    • DOWN 4.0% this week and
    • DOWN 6.9% since the end of January (6 weeks)
      • Has a 69% Chance of Financial Distress within 2 years;
    • Average analyst price target is $14.25, a 136.3% increase from the March 10th price of $6.03
      • The highest analyst price target is $14.25, the lowest forecast is $14.25
      • Consensus rating of Moderate Buy is based on 1 buy rating, 0 hold ratings and 0 sell ratings of 1 Wall Street analyst offering 12 month price targets for Trulieve in the last 3 months Source
    • Read:
  9. Ascend (AAWH): 

  10. Columbia Care (CCHWF): 
    • DOWN 1.6% this week and
    • DOWN 17.8% since the end of January (6 weeks)
      • Has a 72% Chance of Financial Distress within 2 years;
    • Average analyst price target is $1.15, a 91.7% increase from the March 10th price of $0.60
      • The highest analyst price target is $1.15, the lowest forecast is $1.15
      • Consensus rating of Hold is based on 0 buy ratings, 2 hold ratings and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Columbia Care in the last 3 months Source​​​​​​​
    • Read:
  11. Acreage Holdings (ACRDF/ACRHF):
  12. Ayr (AYRWF):
    • DOWN 31.5% this week and
    • DOWN 42.6% since the end of January (6 weeks)
      • Chance of Financial Distress within 2 years: N/A;
    • Average analyst price target is $3.07, a 314.9% increase from the March 10th price of $0.74
      • The highest analyst price target is $4.75, the lowest forecast is $1.38
      • Consensus rating of Moderate Buy is based on 1 buy rating, 1 hold rating and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Columbia Care in the last 3 months Source
    • Read:

More By This Author:

5 Largest Canadian Cannabis LPs - 13% This Week; -26% In Last 6 Weeks
Ayr Wellness Q4 Financials: Operating Loss Increases; EBITDA Improves
MindMed: Researching LSD And MNMA To Treat Neurological Diseases

Disclosure: None  

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.